CYTK

Cytokinetics, Incorporated News Headlines

$7.71
*  
0.25
3.14%
Get CYTK Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading CYTK now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Is It The Right Time To Enter Amgen?
9/18/2013 11:08:00 AM - Seeking Alpha


Cytokinetics: Clinical Investigators' Opinions On ATOMIC-AHF Trial Results
9/4/2013 1:02:00 PM - Seeking Alpha


Cytokinetics: Previewing The Release Of Data From The ATOMIC-AHF Trial Of Omecamtiv Mecarbil
8/26/2013 3:33:00 PM - Seeking Alpha


Cytokinetics: A Preview Of Key Upcoming Clinical Trial Results
8/7/2013 8:39:00 PM - Seeking Alpha


Unreasonable Cause For Selling Cytokinetics
7/9/2013 7:22:00 AM - Seeking Alpha


Cramer's Mad Money - Noodles & Company Is The Son Of Chipotle (7/1/13)
7/2/2013 6:00:00 AM - Seeking Alpha


Cytokinetics: Another Positive Deal For Shareholders, This Time With Astellas
6/25/2013 12:16:00 PM - Seeking Alpha


Amgen In Focus
6/19/2013 9:13:00 AM - Seeking Alpha


Why The Amgen And Cytokinetics Agreement Is Good News
6/13/2013 5:35:00 AM - Seeking Alpha


Cytokinetics Receives A Vote Of Confidence From Amgen
6/13/2013 4:43:00 AM - Seeking Alpha


4 Biotech Stocks Offering Potential, Pipeline And Price
5/29/2013 3:07:00 PM - Seeking Alpha


SmithOnStocks Opines On Recent Biotech News
5/13/2013 5:38:00 AM - Seeking Alpha


2 High Risk Biotech Stocks Under $2 That Could Yield A High Reward
4/17/2013 10:48:00 AM - Seeking Alpha


Cytokinetics: Key Issues For Beginning Phase III For Omecamtiv Mecarbil In Congestive Heart Failure
4/11/2013 1:14:00 PM - Seeking Alpha


Cytokinetics Growth-By-Partnership Strategy Looks Viable When It Comes To CK-2127107
4/2/2013 3:27:00 AM - Seeking Alpha


George Zavoico: Biotech Stocks That Deserve A Closer Look
3/8/2013 3:15:00 AM - Seeking Alpha


Cytokinetics' New Rally Pauses On Buyer Exhaustion
1/18/2013 6:32:00 PM - Seeking Alpha


Cytokinetics' Promising Pipeline: Value Stock for a Long-Term Investor
7/20/2011 3:47:00 AM - Seeking Alpha


16 Small Caps With Cash to Cover 1+ Years of Operating Expenses
4/20/2011 4:00:00 AM - Seeking Alpha


22 Companies With Market Cap Over $50 Million and 100%-Plus Sales Growth Forecast for 2011-12
2/28/2011 10:46:00 AM - Seeking Alpha


Cytokinetics/Amgen Plan Boosts Optimism for Heart Failure Drug
2/9/2011 3:01:00 PM - Seeking Alpha


Value Trap or Play? 12 Stocks Hitting New Lows
1/20/2011 7:42:00 PM - Seeking Alpha


Cytokinetics: Most Recent Victim of Unjustified Biotech Sell-Off
12/19/2010 7:57:00 AM - Seeking Alpha


Cytokinetics ALS Data Raises Hopes, May Be Onto Something
12/15/2010 2:33:00 PM - Seeking Alpha


Monday Options Update: CYTK, SNDK, XCO, GIII & CFN
12/13/2010 4:11:00 PM - Seeking Alpha